Proteomic analysis reveals important role of 14-3-3σ in anoikis resistance of cholangiocarcinoma cells

Proteomics

Volumn 13, Issue 21, 2013, Pages 3157-3166

  Khongmanee, Amnart ^a   Lirdprapamongkol, Kriengsak ^b   Tit oon, Phanthakarn ^a   Chokchaichamnankit, Daranee ^b   Svasti, Jisnuson ^a,b   Srisomsap, Chantragan ^b  

^a Research and Innovation   (Thailand)

^b Krung Thep Maha Nakhon   (Thailand)

Author keywords

14 3 3 Sigma; Anoikis resistance; Cell biology; Cholangiocarcinoma; Metastasis

Indexed keywords

SMALL INTERFERING RNA; STRATIFIN;

ANOIKIS; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; GENE SILENCING; GLYCOLYSIS; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; UPREGULATION;

14-3-3 SIGMA; ANOIKIS RESISTANCE; CELL BIOLOGY; CHOLANGIOCARCINOMA; METASTASIS;

14-3-3 PROTEINS; ANOIKIS; CELL ADHESION; CELL LINE, TUMOR; CELL SHAPE; CHOLANGIOCARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXORIBONUCLEASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEOME; PROTEOMICS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84887078848     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300219     Document Type: Article

References (35)

1. Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E. et al., Liver fluke induces cholangiocarcinoma. PLoS Med. 2007, 4, e201.
2. Khan, S. A., Thomas, H. C., Davidson, B. R., Taylor-Robinson, S. D., Cholangiocarcinoma. Lancet 2005, 366, 1303-1314.
3. Hyun, S. Y., Lee, J. H., Shin, H. S., Lee, S. W. et al., Cutaneous metastasis from cholangiocarcinoma as the first clinical sign: a report of two cases. Gut Liver 2011, 5, 100-104.
4. Yanagi, T., Matsumura, T., Yoshizaki, N., Cholangiocarcinoma with skin metastases. J. Am. Acad. Dermatol. 2007, 56, S58-60.
5. Nguyen, D. X., Massague, J., Genetic determinants of cancer metastasis. Nat. Rev. Genet. 2007, 8, 341-352.
6. Frisch, S. M., Francis, H., Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124, 619-626.
7. Wei, L., Yang, Y., Zhang, X., Yu, Q., Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004, 23, 9052-9061.
8. Zhu, P., Tan, M. J., Huang, R. L., Tan, C. K. et al., Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011, 19, 401-415.
9. Derksen, P. W., Liu, X., Saridin, F., van der Gulden, H. et al., Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10, 437-449.
10. Kanayama, S., Yamada, Y., Kawaguchi, R., Tsuji, Y. et al., Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncol. Rep. 2008, 19, 117-122.
11. Sirisinha, S., Tengchaisri, T., Boonpucknavig, S., Prempracha, N. et al., Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer. Asian Pac. J. Allergy Immunol. 1991, 9, 153-157.
12. Srisomsap, C., Sawangareetrakul, P., Subhasitanont, P., Panichakul, T. et al., Proteomic analysis of cholangiocarcinoma cell line. Proteomics 2004, 4, 1135-1144.
13. Rattanasinganchan, P., Leelawat, K., Treepongkaruna, S. A., Tocharoentanaphol, C. et al., Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J. Gastroenterol. 2006, 12, 6500-6506.
14. Srisomsap, C., Sawangareetrakul, P., Subhasitanont, P., Chokchaichamnankit, D. et al., Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J. Biomed. Biotechnol., 2010, 437143-1-18.
15. Livak, K. J., Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25, 402-408.
16. Feng, J., Yang, S., Xu, L., Tian, H. et al., Role of caspase-3 inhibitor in induced anoikis of mesenchymal stem cells in vitro. J. Huazhong Univ. Sci. Technol. Med. Sci. 2007, 27, 183-185.
17. Giannoni, E., Buricchi, F., Grimaldi, G., Parri, M. et al., Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ. 2008, 15, 867-878.
18. Klopfleisch, R., Klose, P., Weise, C., Bondzio, A. et al., Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. J. Proteome. Res. 2010, 9, 6380-6391.
19. Thongwatchara, P., Promwikorn, W., Srisomsap, C., Chokchaichamnankit, D. et al., Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol. Rep. 2011, 26, 185-191.
20. Yoshida, A., Okamoto, N., Tozawa-Ono, A., Koizumi, H. et al., Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies. Hum. Cell 2013, 26, 56-66.
21. Mishra, S., Ande, S. R., Nyomba, B. L., The role of prohibitin in cell signaling. FEBS J. 2010, 277, 3937-3946.
22. Peng, X., Mehta, R., Wang, S., Chellappan, S., Mehta, R. G., Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res. 2006, 66, 7361-7369.
23. Sievers, C., Billig, G., Gottschalk, K., Rudel, T., Prohibitins are required for cancer cell proliferation and adhesion. PLoS One 2010, 5, e12735.
24. Shoshan-Barmatz, V., de Pinto, V., Zweckstetter, M., Raviv, Z. et al., VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 2010, 31, 227-285.
25. Fu, H., Subramanian, R. R., Masters, S. C., 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617-647.
26. Perathoner, A., Pirkebner, D., Brandacher, G., Spizzo, G. et al., 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin. Cancer Res. 2005, 11, 3274-3279.
27. Neupane, D., Korc, M., 14-3-3 sigma modulates pancreatic cancer cell survival and invasiveness. Clin. Cancer Res. 2008, 14, 7614-7623.
28. Ito, K., Suzuki, T., Akahira, J., Sakuma, M. et al., 14-3-3sigma in endometrial cancer-a possible prognostic marker in early-stage cancer. Clin. Cancer Res. 2005, 11, 7384-7391.
29. Akahira, J., Sugihashi, Y., Suzuki, T., Ito, K. et al., Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin. Cancer Res. 2004, 10, 2687-2693.
30. Li, Z., Liu, J. Y., Zhang, J. T., 14-3-3sigma, the double-edged sword of human cancers. Am. J. Transl. Res. 2009, 1, 326-340.
31. Darby, I. A., Vuillier-Devillers, K., Pinault, E., Sarrazy, V. et al., Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma. Cancer Microenviron. 2010, 4, 73-91.
32. Wu, Q., Liu, C. Z., Tao, L. Y., Yu, L. et al., The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry. Asian Pac. J. Cancer Prev. 2012, 13, 1253-1259.
33. Yeh, C. N., Pang, S. T., Jung, S. M., Chen, T. W. et al., Cytoplasmic overexpression with membrane accentuation of stratifin in intrahepatic mass-forming cholangiocarcinoma after hepatectomy: correlation with clinicopathologic features and patient survival. J. Surg. Oncol. 2010, 102, 608-614.
34. Li, Z., Zhao, J., Du, Y., Park, H. R. et al., Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc. Natl. Acad. Sci. USA 2008, 105, 162-167.
35. Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C., de Boer, J., Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 2013, 31, 108-115.